|
STAU1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.199200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.971700E-04 |
| Normal-vs-Stage2 |
2.938300E-02 |
| Normal-vs-Stage3 |
4.410000E-01 |
| Normal-vs-Stage4 |
1.391880E-02 |
| Stage1-vs-Stage2 |
8.795400E-01 |
| Stage1-vs-Stage3 |
9.303800E-02 |
| Stage1-vs-Stage4 |
8.174800E-01 |
| Stage2-vs-Stage3 |
3.168800E-01 |
| Stage2-vs-Stage4 |
7.558400E-01 |
| Stage3-vs-Stage4 |
2.726400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.957480E-03 |
| Normal-vs-AfricanAmerican |
2.795200E-03 |
| Normal-vs-Asian |
1.479940E-02 |
| Caucasian-vs-AfricanAmerican |
4.771400E-01 |
| Caucasian-vs-Asian |
4.785400E-01 |
| AfricanAmerican-vs-Asian |
6.057800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.226450E-04 |
| Normal-vs-Female |
2.269600E-01 |
| Male-vs-Female |
5.655900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.227900E-04 |
| Normal-vs-Extreme_Weight |
1.047740E-04 |
| Normal-vs-Obese |
9.176400E-02 |
| Normal-vs-Extreme_Obese |
1.237310E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.328200E-01 |
| Normal_Weight-vs-Obese |
6.695800E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.709000E-01 |
| Extreme_Weight-vs-Obese |
3.102400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.313200E-01 |
| Obese-vs-Extreme_Obese |
9.117800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.157200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.413800E-02 |
| Normal-vs-Age(61-80Yrs) |
1.364900E-04 |
| Normal-vs-Age(81-100Yrs) |
6.183400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.162800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.796000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.780300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.616600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.371760E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.097000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.415200E-04 |
| Normal-VS-Type2 PRCC |
2.157600E-04 |
| Normal-VS-KIRP CIMP |
8.657400E-01 |
| Normal-VS-Unclassified PRCC |
8.309600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.225800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.741800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.938200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.687880E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.517830E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.929400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.989300E-04 |
| Normal-vs-N1 |
6.330600E-01 |
| Normal-vs-N2 |
4.674600E-01 |
| N0-vs-N1 |
3.535900E-02 |
| N0-vs-N2 |
4.718000E-01 |
| N1-vs-N2 |
7.693800E-01 |
|
|
